1. Home
  2. MXCT vs MNSB Comparison

MXCT vs MNSB Comparison

Compare MXCT & MNSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MXCT
  • MNSB
  • Stock Information
  • Founded
  • MXCT 1999
  • MNSB 2003
  • Country
  • MXCT United States
  • MNSB United States
  • Employees
  • MXCT N/A
  • MNSB N/A
  • Industry
  • MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • MNSB Major Banks
  • Sector
  • MXCT Health Care
  • MNSB Finance
  • Exchange
  • MXCT Nasdaq
  • MNSB Nasdaq
  • Market Cap
  • MXCT 159.9M
  • MNSB 170.1M
  • IPO Year
  • MXCT 2021
  • MNSB N/A
  • Fundamental
  • Price
  • MXCT $1.76
  • MNSB $18.74
  • Analyst Decision
  • MXCT Buy
  • MNSB
  • Analyst Count
  • MXCT 4
  • MNSB 0
  • Target Price
  • MXCT $7.50
  • MNSB N/A
  • AVG Volume (30 Days)
  • MXCT 841.1K
  • MNSB 32.0K
  • Earning Date
  • MXCT 11-05-2025
  • MNSB 10-17-2025
  • Dividend Yield
  • MXCT N/A
  • MNSB 2.09%
  • EPS Growth
  • MXCT N/A
  • MNSB N/A
  • EPS
  • MXCT N/A
  • MNSB N/A
  • Revenue
  • MXCT $35,754,000.00
  • MNSB $64,604,000.00
  • Revenue This Year
  • MXCT N/A
  • MNSB $23.19
  • Revenue Next Year
  • MXCT $14.80
  • MNSB $2.92
  • P/E Ratio
  • MXCT N/A
  • MNSB N/A
  • Revenue Growth
  • MXCT N/A
  • MNSB N/A
  • 52 Week Low
  • MXCT $1.26
  • MNSB $15.00
  • 52 Week High
  • MXCT $5.20
  • MNSB $22.98
  • Technical
  • Relative Strength Index (RSI)
  • MXCT 57.62
  • MNSB 23.82
  • Support Level
  • MXCT $1.52
  • MNSB $18.81
  • Resistance Level
  • MXCT $1.84
  • MNSB $19.77
  • Average True Range (ATR)
  • MXCT 0.11
  • MNSB 0.44
  • MACD
  • MXCT 0.02
  • MNSB -0.15
  • Stochastic Oscillator
  • MXCT 79.22
  • MNSB 1.92

About MXCT MaxCyte Inc.

MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

About MNSB MainStreet Bancshares Inc.

MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.

Share on Social Networks: